Pharm Delve Cognizance
Aug 16, 2016
To download the pdf version of the Newsletter: Click the following
DelveInsight Newsletter
Downloads
Article in PDF
Recent Articles
- Novartis’s Entresto; AZ, J&J and Lilly sharply cut death rates; CAR-T drugs worth; FDA warns
- Bispecific and Trispecific Antibodies: Are They Better Than CAR-Ts?
- Immuno-Oncology (I-O) Therapeutics: The Key to Future Cancer Treatment
- Gilead Sciences Introduces Sovaldi: A Potent Hepatitis C Treatment
- Snippet
Downloads
Article in PDF
Recent Articles
- Natural Killer Cell Therapies– Advancing technology increasing competition among the companies
- Collaboration provides new insight into cancer treatment
- Novartis’ Canakinumab for NSCLC; Novartis’s Zolgensma Updates; Trodelvy Prospects in New Breast C...
- AKT Inhibitors: A potential Cancer Immunotherapy Target
- PI3Kγ- a molecular switch that controls immune suppression
